Patients with rare cardiovascular diseases face significant diagnostic delays and travel burdens, highlighting the need for coordinated efforts across healthcare and regulatory systems.
Diagnostic travel and consultation burdens persist in rare cardiovascular diseases; leaves open the impact of coordinated referral systems on timely diagnosis.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Podolec et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: